DISCUSSION ONE - THE FUTURE OF PANDEMICS
Presented Virtually on Wednesday, September 29, 2021
6:00pm - 7:30pm
Discussion will be 6:00 - 7:00pm, followed by 30 minutes of Q&A
Pandemic Discussion- Recorded September 29, 2021
Topics to be discussed may include:
- Why are there different responses to the pandemic at varying levels of governance/influence? Is it possible to reconcile those in the future to create a more unified approach to combating pandemics?
- How do we create an appropriate balance between addressing immediate health concerns and considering longer-term effects of restricting economic and cultural activity?
- What do we need to do in this country and beyond to address health disparities (across racial, gender and socioeconomic categories, in particular) that are amplified in the time of pandemic?
Future of Pandemics Recorded on September 29, 2021
Danielle Gilliam, PharmD, MPH
Dr. Gilliam is a Senior Obesity Medical Liaison (ML) with Novo Nordisk Inc. Dr. Gilliam has thorough knowledge of cardiometabolic disease (e.g. obesity, diabetes, NASH) and the science that supports NNI products within those disease states. Her 20 years in the field of diabetes and obesity includes clinical, research and community experience. Dr. Gilliam is certified in health disparities diabetes education, medical writing and editing and she speaks about how diseases like COVID intersect with health disparities. She is a certified lifestyle coach for the National Diabetes Prevention Program and also serves as President of the Community Leadership Board Phoenix Chapter for the American Diabetes Association. She is the Arizona State Conference Health Chair for the NAACP and sits on the board for the Arizona Obesity Organization.
Vin Gupta, MD, MPA
Dr. Gupta is a Critical Care Pulmonologist and Affiliate Faculty at the Institute for Health Metrics and Evaluation, part of the University of Washington. He’s currently Principal Scientist and Chief Medical Officer of COVID-19 Response for Amazon.com, Inc. He was previously helping to lead clinical strategy for Amazon Care before the pandemic, and prior to that, helped lead the pulmonary roadmap for the Apple Series 6 product launch in a part-time role at Apple. Prior to his career in health technology, his background focused on epidemic preparedness, with relevant roles at the US CDC’s Emerging Infections Program, the World Bank’s Pandemic Emergency Financing Facility, and the Pentagon’s Center for Global Health Engagement. Additionally, he is a Major in the US Air Force Medical Corps Reserve (Officer-in-Charge of the Critical Care Air Transport Team capability at Joint-Base Lewis McChord), medical advisor to the NFL and MLB, and medical analyst for NBC and MSNBC News.
Gabriel Sanchez, PhD
Dr. Sanchez is Professor of Political Science and the Founding Robert Wood Johnson Foundation Endowed Chair in Health Policy at the University of New Mexico. An alumnus of the University of Arizona, Dr. Sanchez is also the Rubenstein Fellow in Governance Studies at The Brookings Institution and is a nationally recognized expert in survey research and the utilization of rigorous research to inform public policy decisions at the federal, state, and local levels. He is leading several research projects focused on the impact of COVID-19 on the Latino and Native American communities and undertakes work to strengthen civic engagement.